Stewart Craig
Chief Manufacturing Officer
orchard Therapeutics
Switzerland
Biography
Stewart has more than 30 years of experience in development, cGMP manufacturing, quality systems and regulatory affairs for complex biologicals. For the past 20 years he has held executive level positions designing, implementing and operating the CMC and GMP manufacturing infrastructure for various public and private cell and gene therapy companies, including Sangamo BioSciences, StemCells Inc., Progenitor Cell Therapy, Xcyte Therapies, Osiris Therapeutics, and SyStemix, Inc. He has successfully led development, manufacture and clinical delivery of HSPCs, MSCs, NSCs, activated T cells, gene-modified T cells & gene-modified HSPCs. He also has extensive experience in regulatory affairs with successful cell and gene therapy submissions in US, Canada and Europe.
Research Interest
medical feilds